Skip to content

The Role of Probiotics in Improving Quality of Life in Women With Functional Constipation

The Role of Probiotics in Improving Quality of Life in Women With Functional Constipation: Randomized Double-blind Controlled Trial

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03829358
Enrollment
76
Registered
2019-02-04
Start date
2018-02-24
Completion date
2018-07-21
Last updated
2019-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation - Functional

Keywords

Constipation, Quality of Life, Probiotic, PAC-QOL

Brief summary

This study aimed to investigate the relationship between administration of probiotics and improvement in quality of life in women with functional constipation.

Interventions

Fermented milk containing probiotic Lactobacillus plantarum IS-10506 to be consumed once daily for three weeks.

DRUGPlacebo

Fermented milk containing placebo to be consumed once daily for three weeks.

Sponsors

United States Agency for International Development (USAID)
CollaboratorFED
Fakultas Kedokteran Universitas Indonesia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Being declared healthy based on initial examination and the Structured Interview Questionnaire (SIQ) * Having the symptoms and signs of functional constipation refer to ROME IV * Able to communicate well * Able to consume 1 bottle of fermented milk each day for three weeks * Not using antibiotic no later than one week before supplementation

Exclusion criteria

* Diagnosed with functional bowel disorder * Using anesthesia at least 4 weeks before treatment * Having a serious pathological disorder (carcinoma) * During healing phase of acute gastrointestinal disorders at least 4 weeks before treatment * Having severe heart disease * Taking chronic medications such as antidepressants or analgesics

Design outcomes

Primary

MeasureTime frameDescription
Improvement in quality of lifeThree weeks after intervention.Improvement in quality of life were assessed using PAC-QOL© (Patient Assessment of Constipation - Quality of Life) questionnaire, consisting of four domains: physical discomfort, psychosocial discomfort, worries/concerns, and satisfaction. * Physical discomfort, minimum score 0, maximum score 16, lower value represents better outcome * Psychosocial discomfort, minimum score 0, maximum score 32, lower value represents better outcome * Worries/concerns, minimum score 0, maximum score 44, lower value represents better outcome * Satisfaction, minimum score 0, maximum score 20, higher value represents better outcome Total score = physical discomfort + psychosocial discomfort + worries/concerns - satisfaction • Total score, minimum score -20, maximum score 92, lower value represents better outcome

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026